Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ALVO

Alvotech

Nov 05 • 04:00PM ET

4.88

+0.05 1.04 %

Healthcare • Drug Manufacturers - Specialty & Generic • Luxembourg • NASD

Peers: ABBV PFE MRK LLY AMGN BIIB VRTX GILD REGN BMY

| Held by: IBB PRFZ BIB IBBQ GLCR STXK RFLR

Scroll to Statements

Index	-	P/E	23.25	EPS (ttm)	0.21	Insider Own	63.90%	Shs Outstand	301.81M	Perf Week	-38.23%
Market Cap	1.47B	Forward P/E	8.10	EPS next Y	0.60	Insider Trans	0.00%	Shs Float	108.97M	Perf Month	-43.52%
Enterprise Value	2.59B	PEG	-	EPS next Q	-0.02	Inst Own	5.89%	Short Float	1.52%	Perf Quarter	-42.18%
Income	63.36M	P/S	2.63	EPS this Y	117.54%	Inst Trans	0.03%	Short Ratio	3.34	Perf Half Y	-38.54%
Sales	560.10M	P/B	-	EPS next Y	294.68%	ROA	5.15%	Short Interest	1.66M	Perf YTD	-63.11%
Book/sh	-0.57	P/C	9.72	EPS next 5Y	-	ROE	-	52W High	13.70 -64.38%	Perf Year	-62.52%
Cash/sh	0.50	P/FCF	-	EPS past 3/5Y	- -30.68%	ROIC	6.12%	52W Low	4.70 3.83%	Perf 3Y	-21.29%
Dividend Est.	-	EV/EBITDA	30.05	Sales past 3/5Y	- -	Gross Margin	53.68%	Volatility	8.18% 4.92%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.62	EPS Y/Y TTM	109.02%	Oper. Margin	9.37%	ATR (14)	0.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	98.37%	Profit Margin	11.31%	RSI (14)	17.90	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.82	EPS Q/Q	-54.50%	SMA20	-37.23%	Beta	0.16	Target Price	12.59
Payout	-	Debt/Eq	-	Sales Q/Q	-12.83%	SMA50	-39.14%	Rel Volume	1.84	Prev Close	4.83
Employees	1032	LT Debt/Eq	-	Earnings	Nov 12 AMC	SMA200	-48.70%	Avg Volume	496.70K	Price	4.88
IPO	Nov 09, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	165.51% 47.63%	Trades		Volume	898,101	Change	1.04%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-04-25	Downgrade	Deutsche Bank	Buy → Hold	$8
Oct-14-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$14
Sep-23-25	Upgrade	Deutsche Bank	Hold → Buy	$14
Feb-14-25	Initiated	UBS	Buy	$18
Jan-29-24	Upgrade	Barclays	Equal Weight → Overweight	$10 → $17
Oct-20-23	Upgrade	Citigroup	Sell → Neutral	$5 → $10
Sep-21-23	Initiated	Barclays	Equal Weight	$10
Sep-07-22	Initiated	Morgan Stanley	Equal-Weight	$10
Sep-06-22	Downgrade	Citigroup	Buy → Sell	$12 → $5
Jul-26-22	Initiated	Citigroup	Buy	$12

Nov-05-25 10:00AM	Analysts Estimate Alvotech (ALVO) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-04-25 04:01PM	Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update (GlobeNewswire)
02:00AM	Alvotech faces FDA setback for its Simponi biosimilar AVT05 (Pharmaceutical Technology)
Nov-02-25 05:12PM	Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05 (GlobeNewswire)
11:32AM	Loading…
Oct-27-25 11:32AM	Dr. Reddy's Q2 Earnings Beat Estimates, Generics Sales Boost Revenues (Zacks)
Oct-22-25 05:00AM	Alvotech Announces Changes in Global Business Development and Commercial Operations Team (GlobeNewswire)
Oct-21-25 03:53AM	Strength Seen in Cartesian Therapeutics, Inc. (RNAC): Can Its 8.2% Jump Turn into More Strength? (Zacks)
Oct-15-25 09:55AM	Wall Street Analysts See a 105.88% Upside in Alvotech (ALVO): Can the Stock Really Move This High? (Zacks) +5.65%
Oct-09-25 10:19AM	Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? (Zacks)
Oct-06-25 08:00AM	Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR (omalizumab) (Business Wire)
04:40AM	European Marketing Application for AVT23, a Proposed Biosimilar to Xolair (omalizumab), Accepted by the European Medicines Agency (GlobeNewswire)
Sep-30-25 09:15AM	Here's How Alvotech is Expanding its Portfolio Beyond Immunology (Zacks)
Sep-24-25 03:42AM	Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains? (Zacks)
Sep-23-25 12:19PM	Alvotech vs. Teva Pharma: Which Generic Drugmaker is the Better Play? (Zacks) +8.61%
06:15AM	Loading…
Sep-22-25 06:15AM	European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia and Xgeva (GlobeNewswire)
04:30AM	European Medicines Agency Recommends Marketing Approval of Gobivaz, Alvotech's Proposed Biosimilar to Simponi (golimumab) with Advanz Pharma as Commercialization Partner (GlobeNewswire)
Sep-19-25 07:45AM	Alvotech Announces Marketing Approval in Japan of Three New Biosimilars (GlobeNewswire)
Sep-18-25 09:33AM	Here's How ALVO's Commercial Partnerships Are Driving Top-line Growth (Zacks)
Sep-09-25 09:09AM	ALVO Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell? (Zacks)
Sep-04-25 09:15AM	Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York (GlobeNewswire)
Aug-21-25 04:30AM	Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea (GlobeNewswire)
Aug-20-25 06:05AM	Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia (GlobeNewswire) -5.41%
Aug-14-25 11:41AM	Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks) -5.41%
Aug-13-25 05:40PM	Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update (GlobeNewswire)
09:55AM	Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet (Zacks)
Aug-12-25 03:00PM	ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
10:26AM	Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus (Zacks)
10:16AM	Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks)
05:15PM	Loading…
Aug-06-25 05:15PM	Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT (GlobeNewswire)
Jul-30-25 10:11AM	Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
Jul-24-25 11:21AM	Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues (Zacks)
09:55AM	Wall Street Analysts See a 91.05% Upside in Alvotech (ALVO): Can the Stock Really Move This High? (Zacks)
Jul-17-25 09:35AM	Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO) (Zacks)
Jul-16-25 09:39AM	Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group (Insider Monkey)
Jul-10-25 04:40AM	Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer (GlobeNewswire)
04:40AM	Alvotech Appoints Linda Jonsdottir as Chief Financial Officer (GlobeNewswire)
Jul-09-25 08:59AM	Alvotech expands biosimilars capabilities with Ivers-Lee acquisition (Packaging Gateway)
04:30AM	Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland (GlobeNewswire)
04:30AM	Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland (GlobeNewswire)
Jul-06-25 04:15AM	Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma (Insider Monkey)
Jul-03-25 07:02PM	Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers (GlobeNewswire)
Jul-01-25 07:54PM	Granting of Stock Options and Vesting of Restricted Share Units (GlobeNewswire)
04:00AM	Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia (certolizumab pegol) (GlobeNewswire)
Jun-26-25 10:25AM	Alvotech, Kashiv, Advanz announce study of AVT23 met primary endpoint (TipRanks)
04:15AM	Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility (GlobeNewswire)
Jun-25-25 04:45PM	Main Results of 2025 Annual and Extraordinary General Meeting (GlobeNewswire)
04:00AM	Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair (omalizumab) (GlobeNewswire)
Jun-24-25 09:05AM	Alvotech (ALVO): A Bull Case Theory (Insider Monkey)
Jun-23-25 04:00AM	European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea (aflibercept) (GlobeNewswire)
Jun-11-25 04:20PM	Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors (GlobeNewswire)
Jun-09-25 09:55AM	Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet (Zacks)
Jun-06-25 08:30AM	Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami (GlobeNewswire)
08:30AM	Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami (GlobeNewswire)
08:18AM	Alvotech and Dr. Reddy's partner for Keytruda biosimilar (Pharmaceutical Business Review)
Jun-05-25 11:28AM	RDY & ALVO Ink Collaboration Deal for Merck's Keytruda Biosimilar (Zacks)
07:00AM	Alvotech and Dr. Reddys Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda (pembrolizumab) (Business Wire)
Jun-04-25 10:29PM	Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million (GlobeNewswire) -5.41%
11:32AM	Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares (GlobeNewswire)
07:45AM	Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia (GlobeNewswire)
Jun-02-25 09:15AM	Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY (GlobeNewswire)
May-28-25 06:15AM	Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe (GlobeNewswire)
May-26-25 02:06PM	Alvotech Annual General Meeting to be held June 25, 2025 (GlobeNewswire)
May-23-25 12:11PM	Transactions of Managers and Closely Associated Persons (GlobeNewswire)
May-19-25 03:15AM	Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm (GlobeNewswire)
02:30AM	Trading in Alvotech's Shares on Nasdaq Stockholm Commences Today (GlobeNewswire)
May-16-25 01:52PM	Alvotech Announces the Outcome of the Offering in Connection with the Company's Listing on Nasdaq Stockholm (GlobeNewswire)
10:28AM	Transactions of Managers and Closely Associated Persons (GlobeNewswire)
May-13-25 04:05AM	Transactions of Managers and Closely Associated Persons (GlobeNewswire)
May-12-25 09:20AM	RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up (Zacks) +5.89%
May-09-25 08:45AM	Is Alvotech (ALVO) The Best Stock That Will Bounce Back? (Insider Monkey)
08:00AM	Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada (GlobeNewswire)
07:17AM	Transactions of Managers and Closely Associated Persons (GlobeNewswire)
May-08-25 02:30AM	Alvotech Publishes Prospectus in Connection with its Listing on Nasdaq Stockholm (GlobeNewswire) +18.14%
May-07-25 04:45PM	Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update (GlobeNewswire)
06:20AM	Alvotech sees minimal impact on 2025 product revenues from tariffs (Seeking Alpha)
05:00AM	Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025 (GlobeNewswire)
May-05-25 07:00AM	Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with Stelara (ustekinumab) (GlobeNewswire)
May-02-25 08:30AM	Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT (GlobeNewswire)
08:30AM	Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT (14:00 CET) (GlobeNewswire)
Apr-30-25 04:39PM	Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade) (Seeking Alpha)
Apr-27-25 11:40PM	Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results (Seeking Alpha)
Apr-25-25 06:33AM	New Strong Sell Stocks for April 25th (Zacks) -5.14%
Apr-24-25 07:46AM	Johnson & Johnson Just Proved The Bears Wrong Again (Seeking Alpha)
Apr-17-25 05:27AM	New Strong Sell Stocks for April 17th (Zacks)
Mar-31-25 09:30AM	RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar (Zacks)
Mar-28-25 05:01PM	This Is a Test From GlobeNewswire (GlobeNewswire) -7.82%
Mar-27-25 12:09PM	Alvotech (ALVO) Q4 2024 Earnings Call Transcript (SeekingAlpha) -10.30%
04:30AM	Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer (GlobeNewswire)
Mar-26-25 06:36PM	Alvotech Reports Record Results for 2024 and Provides Business Update (GlobeNewswire)
04:30AM	UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair (omalizumab) (GlobeNewswire)
Mar-20-25 04:09AM	Alvotech acquires Xbrane's R&D operations in Sweden and biosimilar candidate XB003 (SeekingAlpha)
03:00AM	Alvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production (GlobeNewswire)
Mar-19-25 11:13AM	FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review (Zacks)
07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-18-25 08:35AM	Alvotech and Dr. Reddys Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva (Business Wire)
Mar-07-25 09:00AM	Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida (GlobeNewswire)
Feb-24-25 08:00AM	Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET (GlobeNewswire)

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Robert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALVO

Alvotech

Upgrade your FINVIZ experience